Subtype-specific neuronal differentiation of PC12 cells transfected with α2-adrenergic receptors

https://doi.org/10.1078/0171-9335-00250Get rights and content

Summary

Cells of the PC12 rat pheochromocytoma cell line acquire characteristics of sympathetic neurons under appropriate treatment. Stably transfected PC12 cells expressing individual α2-adrenergic receptor (α2-AR) subtypes were used to assess the role of α2-ARs in neuronal differentiation and to characterise the signalling pathways activated by the α2-AR agonist epinephrine in these cells. The effects of α2-AR activation were compared with the differentiating action and the signalling mechanisms of nerve growth factor (NGF). Epinephrine induced neuronal differentiation of PC12α2 cells through α2-AR activation in a subtype-dependent manner, internalization of all human α2-AR subtypes, and activation of mitogen-activated protein kinase (MAPK) and the serine-threonine protein kinase Akt. Epinephrine and NGF showed synergism in their differentiating effects. The MAPK kinase (MEK-1) inhibitor PD 98059 abolished the differentiating effect of epinephrine indicating that the differentiation is dependent on MAPK activation. Activating protein-1 (AP-1) DNA-binding activity was increased after epinephrine treatment in all three PC12α2 subtype clones. Evaluation of the potential physiological consequences of these findings requires further studies on endogenously expressed α2-ARs in neuronal cells.

References (57)

  • M. Karin

    The regulation of AP-1 activity by mitogen-activated protein kinases

    J. Biol. Chem.

    (1995)
  • K. Kimura et al.

    Neurite outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase

    J. Biol. Chem.

    (1994)
  • S. Liitti et al.

    Subtype specific recognition of human alpha2C2 adrenergic receptor using monoclonal antibodies against the third intracellular loop

    Biochem. Biophys. Res. Commun.

    (1997)
  • E. MacDonald et al.

    Gene targeting– homing in on α2-adrenoceptor-subtype function

    Trends Pharmacol. Sci.

    (1997)
  • A.P. Nicholas et al.

    The distribution and significance of CNS adrenoceptors examined with in situ hybridization

    Trends Pharmacol. Sci.

    (1996)
  • L. Pang et al.

    Inhibition of MAP kinase kinase blocks differentiation of PC12 cells induced by nerve growth factor

    J. Biol. Chem.

    (1995)
  • N.E. Schramm et al.

    Stimulation of mitogen-activated protein kinase by G protein-coupled α2-adrenergic receptors does not require agonist-elicited endocytosis

    J. Biol. Chem.

    (1999)
  • M. Von Zastrow et al.

    Subtype-specific differences in the intracellular sorting of G protein-coupled receptors

    J. Biol. Chem.

    (1993)
  • N.G. Williams et al.

    Differential coupling of α1-, α2- and β-adrenergic receptors to mitogen-activated protein kinase pathways and differentiation in transfected PC12 cells

    J. Biol. Chem.

    (1998)
  • U.H. Winzer-Serhan et al.

    Alpha2B-adrenoceptor mRNA expression during rat brain development

    Brain Res. Dev. Brain Res.

    (1997)
  • B. Binetruy et al.

    Ha-Ras augments c-jun activity and stimulates phosphorylation of its activation domain

    Nature

    (1991)
  • D.B. Bylund et al.

    International Union of Pharmacology nomenclature of adrenoceptors

    Pharmacol. Rev.

    (1994)
  • T.O. Chan et al.

    AKT/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoinositide-dependent phosphorylation

    Annu. Rev. Biochem.

    (1999)
  • D. Cussac et al.

    α2B-adrenergic receptors activate MAPK and modulate the proliferation of primary cultured proximal tubule cells

    Am. J. Physiol. Renal Physiol.

    (2001)
  • S.R. Datta et al.

    Cellular survival: a play in three Akts

    Genes Dev.

    (1999)
  • D.A. Daunt et al.

    Subtype-specific intracellular trafficking of α2-adrenergic receptors

    Mol. Pharmacol.

    (1997)
  • C. Gaiddon et al.

    Brain-derived neurotrophic factor stimulates AP-1 and cyclic AMP-responsive element dependent transcriptional activity in central nervous system neurons

    J. Neurochem.

    (1996)
  • E. Gizang-Ginsberg et al.

    Fos family members successively occupy the tyrosine hydroxylase gene AP-1 site after nerve growth factor or epidermal growth factor stimulation and can repress transcription

    Mol. Endocrinol.

    (1994)
  • Cited by (28)

    • Sustained GRK2-dependent CREB activation is essential for α<inf>2</inf>-adrenergic receptor-induced PC12 neuronal differentiation

      2020, Cellular Signalling
      Citation Excerpt :

      # G9500; Promega US, Madison, WI, USA). For differentiation experiments, cells were plated (50,000 cells/ml) on collagen-coated culture dishes and cultured in DMEM supplemented with 1% horse serum and 10 mM MgCl2 (differentiation medium), as described [9]. For morphological experiments, the percentage of cells showing neurite outgrowth was determined using phase-contrast microscopy.

    • Pharmacological, but not genetic, alteration of neural Epo modifies the CO<inf>2</inf>/H<sup>+</sup> central chemosensitivity in postnatal mice

      2017, Respiratory Physiology and Neurobiology
      Citation Excerpt :

      However, apart from being implicated in the molecular pathway activated by Epo (Caravagna and Soliz, 2015), ERK/Akt are also molecules involved in major processes accomplishing a wide variety of neural tasks, including glucose metabolism (Engelman et al., 2006), cellular apoptosis and survival (Teng et al., 2014), differentiation (Chan et al., 2013), neural proliferation and migration (Dey et al., 2005), neuroprotection (Zhang et al., 2015), neurodegeneration (Fang et al., 2015), and synaptic signalling (Yoshii and Constantine-Paton, 2014). Moreover, ERK/Akt in brain tissue participates in the modulation of dopaminergic (Beaulieu et al., 2006), muscarinic (Rosenblum et al., 2000), adrenergic (Taraviras et al., 2002), serotonergic (Cowen, 2007), GABAergic (Balasubramanian et al., 2004) and adenosinergic (Wiese et al., 2007) neurotransmission. As such, our results are currently limited to explain whether apart from the Epo molecular pathway, ERK/Akt modulates the hypercapnic fictive breathing by affecting other mechanisms.

    • GPCRs of adrenal chromaffin cells &amp; catecholamines: The plot thickens

      2016, International Journal of Biochemistry and Cell Biology
      Citation Excerpt :

      The α2ARs are inhibitory autoreceptors that inhibit further release of CA's in adrenergic nerves in the central sympathetic nervous system (SNS), and in the adrenal medulla (Fig. 1). The predominant inhibitory role of α2ARs in the adrenal gland becomes clear when considering that PC12, a rat pheochromocytoma (chromaffin) cell line does not express these receptors and secretes abnormal catecholamine quantities (Taraviras et al., 2002). However, the mouse and rat adrenal glands, as well as the human adrenal gland (Berkowitz et al., 1994; Lymperopoulos et al., 2007a), normally express various α2AR subtypes endogenously, mainly α2A- and α2CARs (in the murine adrenal gland) (Brede et al., 2003).

    View all citing articles on Scopus
    View full text